Download PDF
CC BY-NC-ND 4.0 · Journal of Cardiac Critical Care TSS
DOI: 10.1055/s-0042-1754161
Original Article

A Randomized Controlled Trial to Evaluate the Use of Probiotics in Prevention of Ventilator-Associated Pneumonia in Critically Ill ICU Patients

Anand Prasoon
1   Department of Trauma and Emergency, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India
,
Ritu Singh
2   Department of Critical Care Medicine, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India
,
Ravi Anand 
1   Department of Trauma and Emergency, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India
,
Sanjeev Kumar
2   Department of Critical Care Medicine, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India
,
Siddharth Singh
1   Department of Trauma and Emergency, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India
,
Akrity Singh
1   Department of Trauma and Emergency, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Context Ventilator-associated pneumonia (VAP) is one of the most common causes of morbidity and mortality in mechanically ventilated patients. Curing and preventing effects of probiotics in promoting the growth of Bifidobacterium in the digestive system and the central role of bacteria colonization in the pathogenesis of VAP are evident.

Aims The purpose of this study was to evaluate the effects of administration of commercially available probiotics, that is, orodispersible probiotic sachets on VAP prevention and clinical outcomes in critically ill patients.

Settings and Design Randomized control trials.

Methods and Materials In this study, 120 mechanically ventilated patients were randomly divided into two groups (n = 60 per group). Group 1 was given orodispersible probiotic sachets by gavage, twice a day in addition to routine care, while group 2 received only routine care. Demographic and clinical data were analyzed and clinical outcomes to the primary component (prevalence of VAP) and secondary component (other clinical factors) were interpreted.

Statistical Analysis Used In this study, data were analyzed via SAS statistical software version 9.4, using Student's t-test, chi-squared test, repeated measure analysis of variance, and Wilcoxon test.

Results There was a significant reduction in VAP diagnosed patients, as well as Clostridium difficile-associated diarrhea and some complications of mechanical ventilation, in group 1 in comparison to group 2. The improvement in VAP was significantly greater for group 1 as compared with group 2. However, the mortality rate was similar between two groups.

Conclusions This study demonstrated that a daily diet with orodispersible probiotic sachets can be used as add-on therapy with other medications in the prevention of VAP. As a result, the use of orodispersible probiotic sachets in the treatment plan of patients undergoing long-term intubation is recommended.

Keywords

ventilator-associated pneumonia - probiotics - diarrhea


Publication History

Article published online:
02 July 2022

© 2022. Official Publication of The Simulation Society (TSS), accredited by International Society of Cardiovascular Ultrasound (ISCU). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India